104 related articles for article (PubMed ID: 15256807)
1. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades.
Jacob J; Bellach J; Grützmann R; Alldinger I; Pilarsky C; Dietel M; Kristiansen G
Pancreatology; 2004; 4(5):454-60. PubMed ID: 15256807
[TBL] [Abstract][Full Text] [Related]
2. CD24 expression is a new prognostic marker in breast cancer.
Kristiansen G; Winzer KJ; Mayordomo E; Bellach J; Schlüns K; Denkert C; Dahl E; Pilarsky C; Altevogt P; Guski H; Dietel M
Clin Cancer Res; 2003 Oct; 9(13):4906-13. PubMed ID: 14581365
[TBL] [Abstract][Full Text] [Related]
3. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.
Kristiansen G; Schlüns K; Yongwei Y; Denkert C; Dietel M; Petersen I
Br J Cancer; 2003 Jan; 88(2):231-6. PubMed ID: 12610508
[TBL] [Abstract][Full Text] [Related]
4. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival.
Weichert W; Denkert C; Burkhardt M; Gansukh T; Bellach J; Altevogt P; Dietel M; Kristiansen G
Clin Cancer Res; 2005 Sep; 11(18):6574-81. PubMed ID: 16166435
[TBL] [Abstract][Full Text] [Related]
6. The role of CD24 in various human epithelial neoplasias.
Lim SC; Oh SH
Pathol Res Pract; 2005; 201(7):479-86. PubMed ID: 16164042
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors.
Choi YL; Kim SH; Shin YK; Hong YC; Lee SJ; Kang SY; Ahn G
Gynecol Oncol; 2005 May; 97(2):379-86. PubMed ID: 15863133
[TBL] [Abstract][Full Text] [Related]
8. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.
Kristiansen G; Denkert C; Schlüns K; Dahl E; Pilarsky C; Hauptmann S
Am J Pathol; 2002 Oct; 161(4):1215-21. PubMed ID: 12368195
[TBL] [Abstract][Full Text] [Related]
9. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer.
Kristiansen G; Pilarsky C; Pervan J; Stürzebecher B; Stephan C; Jung K; Loening S; Rosenthal A; Dietel M
Prostate; 2004 Feb; 58(2):183-92. PubMed ID: 14716744
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
11. Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis.
Hassan R; Laszik ZG; Lerner M; Raffeld M; Postier R; Brackett D
Am J Clin Pathol; 2005 Dec; 124(6):838-45. PubMed ID: 16416732
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients.
Surowiak P; Materna V; Kłak K; Spaczyński M; Dietel M; Kristiansen G; Lage H; Zabel M
Pol J Pathol; 2005; 56(2):69-74. PubMed ID: 16092668
[TBL] [Abstract][Full Text] [Related]
13. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
Su MC; Hsu C; Kao HL; Jeng YM
Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
[TBL] [Abstract][Full Text] [Related]
14. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance.
Lee HJ; Kim DI; Kwak C; Ku JH; Moon KC
Urology; 2008 Sep; 72(3):603-7. PubMed ID: 18384848
[TBL] [Abstract][Full Text] [Related]
16. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
[TBL] [Abstract][Full Text] [Related]
17. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
[TBL] [Abstract][Full Text] [Related]
18. CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer.
Ahmed MA; Al-Attar A; Kim J; Watson NF; Scholefield JH; Durrant LG; Ilyas M
J Clin Pathol; 2009 Dec; 62(12):1117-22. PubMed ID: 19946098
[TBL] [Abstract][Full Text] [Related]
19. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy.
Kwon GY; Ha H; Ahn G; Park SY; Huh SJ; Park W
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1150-6. PubMed ID: 17692475
[TBL] [Abstract][Full Text] [Related]
20. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma.
Torer N; Kayaselcuk F; Nursal TZ; Yildirim S; Tarim A; Nòyan T; Karakayali H
J Surg Oncol; 2007 Oct; 96(5):419-23. PubMed ID: 17874463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
